HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House And Senate Farm Bills Dilemma: Each Includes One, But Not Both Of Supplement Industry's SNAP, Hemp Goals

This article was originally published in The Rose Sheet

Executive Summary

Senate's USDA five-year reauthorization would remove hemp from federal list of controlled substances and lift limits on production in the US but does not contain language included in the House bill to make multivitamins eligible for Supplemental Nutrition Assistance Program purchases. House bill though, doesn't clear hemp production. "I think we have a lot of work of ahead of us on both fronts," says CRN President and CEO Steve Mister.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel